Amrize (NYSE:AMRZ – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03, Zacks reports.
Amrize Trading Down 2.4%
Shares of Amrize stock traded down $1.39 during trading hours on Tuesday, hitting $57.44. The company’s stock had a trading volume of 4,501,199 shares, compared to its average volume of 3,339,046. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97. The stock has a 50 day moving average of $55.50 and a 200 day moving average of $52.18. Amrize has a 12 month low of $44.12 and a 12 month high of $60.57. The company has a market capitalization of $31.77 billion and a PE ratio of 31.22.
Insider Activity
In other news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction on Wednesday, November 19th. The stock was purchased at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the acquisition, the director owned 4,958 shares in the company, valued at approximately $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of equities analysts have recently commented on AMRZ shares. Citigroup raised their price objective on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Royal Bank Of Canada cut shares of Amrize from an “outperform” rating to a “sector perform” rating and raised their price target for the stock from $56.00 to $60.00 in a research note on Monday, December 8th. Deutsche Bank Aktiengesellschaft set a $59.00 price objective on Amrize in a research note on Monday, December 8th. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, February 11th. Finally, Wall Street Zen upgraded shares of Amrize to a “hold” rating in a research report on Saturday, October 25th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Amrize currently has a consensus rating of “Moderate Buy” and an average price target of $60.75.
Get Our Latest Research Report on Amrize
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
- Five stocks we like better than Amrize
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
